The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19

Abstract

SUMMARYSARS-CoV-2 infection is typically very mild and often asymptomatic in children. A complication is the rare Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19, presenting 4-6 weeks after infection as high fever, organ dysfunction and strongly elevated markers of inflammation. The pathogenesis is unclear but has overlapping features with Kawasaki disease suggestive of vasculitis and a likely autoimmune etiology. We apply systems-level analyses of blood immune cells, cytokines and autoantibodies in healthy children, children with Kawasaki disease enrolled prior to COVID-19, children infected with SARS-CoV-2 and children presenting with MIS-C. We find that the inflammatory response in MIS-C differs from the cytokine storm of severe acute COVID-19, shares several features with Kawasaki disease, but also differs from this condition with respect to T-cell subsets, IL-17A and biomarkers associated with arterial damage. Finally, autoantibody profiling suggests multiple autoantibodies that could be involved in the pathogenesis of MIS-C.HIGHLIGHTSHyperinflammation in MIS-C differs from that of acute COVID-19T-cell subsets discriminate Kawasaki disease patients from MIS-CIL-17A drives Kawasaki, but not MIS-C hyperinflammation.Global autoantibodies profiling indicate possibly pathogenic autoantibodies